| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 81, 547-554, Copyright © 1996 by Endocrine Society
ARTICLES |
M Tonacchera, J Van Sande, F Cetani, S Swillens, C Schvartz, P Winiszewski, L Portmann, JE Dumont, G Vassart and J Parma
Institut de Recherche Interdisciplinaire, Faculte de Medecine, Universite Libre de Bruxelles, Belgium.
We report three unrelated families in which hyperthyroidism associated with thyroid hyperplasia was transmitted in an autosomal dominant fashion, in the absence of signs of autoimmunity. Exon 10 of the TSH receptor gene was directly sequenced after PCR amplification from DNA of peripheral leukocytes. In one family, a C to A transversion resulted in an S505R substitution in the third transmembrane segment; in the second, an A to T transversion caused a N650Y substitution in the sixth transmembrane segment; and in the third family, an A to G transition resulted in an N670S substitution in the seventh transmembrane segment. When expressed by transfection in COS-7 cells, each mutated receptor displayed an increase in constitutive stimulation of cAMP production; no effect on basal accumulation of inositol phosphates (IP) could be detected. In binding studies, cells transfected with wild-type or mutated receptors showed similar levels of expression, with the mutated receptors displaying similar or slightly increased affinity for bovine TSH (bTSH) binding. Cells transfected with S505R and N650Y mutants showed a similar cAMP maximal TSH-stimulated accumulation over the cells transfected with the wild type, whereas N670S transfectants showed a blunted response with an increase in EC50. A higher IP response to 100 mU/mL bTSH over that obtained with the wild-type receptor was obtained in cells transfected with N650Y; in contrast, cells transfected with S505R showed a blunted IP production (50% less), and the N670S mutant completely lost the ability to stimulate IP accumulation in response to bTSH. The differential effects of individual mutations on stimulation by bTSH of cAMP or IP accumulation suggest that individual mutant receptors may achieve different active conformations with selective abilities to couple to Gs alpha and to Gq alpha.
This article has been cited by other articles:
![]() |
G. Kleinau, H. Jaeschke, S. Mueller, B. M. Raaka, S. Neumann, R. Paschke, and G. Krause Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor FASEB J, August 1, 2008; 22(8): 2798 - 2808. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kleinau, M. Brehm, U. Wiedemann, D. Labudde, U. Leser, and G. Krause Implications for Molecular Mechanisms of Glycoprotein Hormone Receptors Using a New Sequence-Structure-Function Analysis Resource Mol. Endocrinol., February 1, 2007; 21(2): 574 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kleinau, M. Claus, H. Jaeschke, S. Mueller, S. Neumann, R. Paschke, and G. Krause Contacts between Extracellular Loop Two and Transmembrane Helix Six Determine Basal Activity of the Thyroid-stimulating Hormone Receptor J. Biol. Chem., January 5, 2007; 282(1): 518 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Van Durme, F. Horn, S. Costagliola, G. Vriend, and G. Vassart GRIS: Glycoprotein-Hormone Receptor Information System Mol. Endocrinol., September 1, 2006; 20(9): 2247 - 2255. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ringkananont, J. Van Durme, L. Montanelli, F. Ugrasbul, Y. M. Yu, R. E. Weiss, S. Refetoff, and H. Grasberger Repulsive Separation of the Cytoplasmic Ends of Transmembrane Helices 3 and 6 Is Linked to Receptor Activation in a Novel Thyrotropin Receptor Mutant (M626I) Mol. Endocrinol., April 1, 2006; 20(4): 893 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Claus, H. Jaeschke, G. Kleinau, S. Neumann, G. Krause, and R. Paschke A Hydrophobic Cluster in the Center of the Third Extracellular Loop Is Important for Thyrotropin Receptor Signaling Endocrinology, December 1, 2005; 146(12): 5197 - 5203. [Abstract] [Full Text] [PDF] |
||||
![]() |
S G Watson, A D Radford, A Kipar, P Ibarrola, and L Blackwood Somatic mutations of the thyroid-stimulating hormone receptor gene in feline hyperthyroidism: parallels with human hyperthyroidism J. Endocrinol., September 1, 2005; 186(3): 523 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Karges, G. Krause, J. Homoki, K.-M. Debatin, N. de Roux, and W. Karges TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5 J. Endocrinol., August 1, 2005; 186(2): 377 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Neumann, M. Claus, and R. Paschke Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation Eur. J. Endocrinol., April 1, 2005; 152(4): 625 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Montanelli, J. J. J. Van Durme, G. Smits, M. Bonomi, P. Rodien, E. J. Devor, K. Moffat-Wilson, L. Pardo, G. Vassart, and S. Costagliola Modulation of Ligand Selectivity Associated with Activation of the Transmembrane Region of the Human Follitropin Receptor Mol. Endocrinol., August 1, 2004; 18(8): 2061 - 2073. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Kifor, F. D. Moore Jr., M. Delaney, J. Garber, G. N. Hendy, R. Butters, P. Gao, T. L. Cantor, I. Kifor, E. M. Brown, et al. A Syndrome of Hypocalciuric Hypercalcemia Caused by Autoantibodies Directed at the Calcium-Sensing Receptor J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 60 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Szkudlinski, V. Fremont, C. Ronin, and B. D. Weintraub Thyroid-Stimulating Hormone and Thyroid-Stimulating Hormone Receptor Structure-Function Relationships Physiol Rev, April 1, 2002; 82(2): 473 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Biebermann, T. Schoneberg, C. Hess, J. Germak, T. Gudermann, and A. Gruters The First Activating TSH Receptor Mutation in Transmembrane Domain 1 Identified in a Family with Nonautoimmune Hyperthyroidism J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4429 - 4433. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tonacchera, P. Agretti, G. De Marco, A. Perri, A. Pinchera, P. Vitti, and L. Chiovato Thyroid Resistance to TSH Complicated by Autoimmune Thyroiditis J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4543 - 4546. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Neumann, G. Krause, S. Chey, and R. Paschke A Free Carboxylate Oxygen in the Side Chain of Position 674 in Transmembrane Domain 7 Is Necessary for TSH Receptor Activation Mol. Endocrinol., August 1, 2001; 15(8): 1294 - 1305. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Ho, J. Van Sande, A. Lefort, G. Vassart, and S. Costagliola Effects of Mutations Involving the Highly Conserved S281HCC Motif in the Extracellular Domain of the Thyrotropin (TSH) Receptor on TSH Binding and Constitutive Activity Endocrinology, July 1, 2001; 142(7): 2760 - 2767. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-X. Tao, A. N. Abell, X. Liu, K. Nakamura, and D. L. Segaloff Constitutive Activation of G Protein-Coupled Receptors as a Result of Selective Substitution of a Conserved Leucine Residue in Transmembrane Helix III Mol. Endocrinol., August 1, 2000; 14(8): 1272 - 1282. [Abstract] [Full Text] |
||||
![]() |
J. Pohlenz, L. Duprez, R. E. Weiss, G. Vassart, S. Refetoff, and S. Costagliola Failure of Membrane Targeting Causes the Functional Defect of Two Mutant Sodium Iodide Symporters J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2366 - 2369. [Abstract] [Full Text] |
||||
![]() |
M. Tonacchera, P. Agretti, A. Pinchera, V. Rosellini, A. Perri, P. Collecchi, P. Vitti, and L. Chiovato Congenital Hypothyroidism with Impaired Thyroid Response to Thyrotropin (TSH) and Absent Circulating Thyroglobulin: Evidence for a New Inactivating Mutation of the TSH Receptor Gene J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1001 - 1008. [Abstract] [Full Text] |
||||
![]() |
S. J. Marx CLINICAL REVIEW 109: Contrasting Paradigms for Hereditary Hyperfunction of Endocrine Cells J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3001 - 3009. [Full Text] |
||||
![]() |
E. M. Gabriel, E. R. Bergert, C. S. Grant, J. A. van Heerden, G. B. Thompson, and J. C. Morris Germline Polymorphism of Codon 727 of Human Thyroid-Stimulating Hormone Receptor Is Associated with Toxic Multinodular Goiter J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3328 - 3335. [Abstract] [Full Text] |
||||
![]() |
D. H. C. Khoo, J. Parma, C. Rajasoorya, S. C. Ho, and G. Vassart A Germline Mutation of the Thyrotropin Receptor Gene Associated with Thyrotoxicosis and Mitral Valve Prolapse in a Chinese Family J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1459 - 1462. [Abstract] [Full Text] |
||||
![]() |
A. Grüters, T. Schöneberg, H. Biebermann, H. Krude, H. P. Krohn, H. Dralle, and T. Gudermann Severe Congenital Hyperthyroidism Caused by a Germ-Line neo Mutation in the Extracellular Portion of the Thyrotropin Receptor J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1431 - 1436. [Abstract] [Full Text] |
||||
![]() |
S. Kosugi, T. Mori, and A. Shenker An Anionic Residue at Position 564 Is Important for Maintaining the Inactive Conformation of the Human Lutropin/Choriogonadotropin Receptor Mol. Pharmacol., May 1, 1998; 53(5): 894 - 901. [Abstract] [Full Text] |
||||
![]() |
P. Wonerow, T. Schoneberg, G. Schultz, T. Gudermann, and R. Paschke Deletions in the Third Intracellular Loop of the Thyrotropin Receptor. A NEW MECHANISM FOR CONSTITUTIVE ACTIVATION J. Biol. Chem., April 3, 1998; 273(14): 7900 - 7905. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tonacchera, L. Chiovato, A. Pinchera, P. Agretti, E. Fiore, F. Cetani, R. Rocchi, P. Viacava, P. Miccoli, and P. Vitti Hyperfunctioning Thyroid Nodules in Toxic Multinodular Goiter Share Activating Thyrotropin Receptor Mutations with Solitary Toxic Adenoma J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 492 - 498. [Abstract] [Full Text] |
||||
![]() |
P. J. Fuller, K. Verity, Y. Shen, P. Mamers, T. Jobling, and H. G. Burger No Evidence of a Role for Mutations or Polymorphisms of the Follicle-Stimulating Hormone Receptor in Ovarian Granulosa Cell Tumors J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 274 - 279. [Abstract] [Full Text] |
||||
![]() |
R. Paschke and M. Ludgate The Thyrotropin Receptor in Thyroid Diseases N. Engl. J. Med., December 4, 1997; 337(23): 1675 - 1681. [Full Text] [PDF] |
||||
![]() |
M. A. Levine and M. D. Ringel Resistance to TSH in Patients with Normal TSH Receptors--Where Do We Turn When "Sutton's Law" Proves False? J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3930 - 3932. [Full Text] [PDF] |
||||
![]() |
H.-P. Holzapfel, D. Fuhrer, P. Wonerow, G. Weinland, W. A. Scherbaum, and R. Paschke Identification of Constitutively Activating Somatic Thyrotropin Receptor Mutations in a Subset of Toxic Multinodular Goiters J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4229 - 4233. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fuhrer, P. Wonerow, H. Willgerodt, and R. Paschke Identification of a New Thyrotropin Receptor Germline Mutation (Leu629Phe) in a Family with Neonatal Onset of Autosomal Dominant Nonautoimmune Hyperthyroidism J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4234 - 4238. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-P. Holzapfel, P. Wonerow, W. von Petrykowski, M. Henschen, W. A. Scherbaum, and R. Paschke Sporadic Congenital Hyperthyroidism due to a Spontaneous Germline Mutation in the Thyrotropin Receptor Gene J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3879 - 3884. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fuhrer, H.-P. Holzapfel, P. Wonerow, W. A. Scherbaum, and R. Paschke Somatic Mutations in the Thyrotropin Receptor Gene and Not in the Gs{alpha} Protein Gene in 31 Toxic Thyroid Nodules J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3885 - 3891. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Parma, L. Duprez, J. Van Sande, J. Hermans, P. Rocmans, G. Van Vliet, S. Costagliola, P. Rodien, J. E. Dumont, and G. Vassart Diversity and Prevalence of Somatic Mutations in the Thyrotropin Receptor and Gs{alpha} Genes as a Cause of Toxic Thyroid Adenomas J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2695 - 2701. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Esapa, S. Foster, S. Johnson, J. L. Jameson, P. Kendall-Taylor, and P. E. Harris G Protein and Thyrotropin Receptor Mutations in Thyroid Neoplasia J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 493 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kosugi, T. Mori, and A. Shenker The Role of Asp578 in Maintaining the Inactive Conformation of the Human Lutropin/Choriogonadotropin Receptor J. Biol. Chem., December 13, 1996; 271(50): 31813 - 31817. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Govaerts, A. Lefort, S. Costagliola, S. J. Wodak, J. A. Ballesteros, J. Van Sande, L. Pardo, and G. Vassart A Conserved Asn in Transmembrane Helix 7 Is an On/Off Switch in the Activation of the Thyrotropin Receptor J. Biol. Chem., June 15, 2001; 276(25): 22991 - 22999. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |